• Markets
    • icon
  • Companies
HLS · ASX

Healius Limited (ASX:HLS)

AU$1.46

 -0.005 (-0.34%)
ASX:Live
26/07/2024 04:10:15 PM
Hammer Bullish HALO Small HALO Ords HALO 200 GROWTH AUS +3
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

HLS Overview

HLS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Very Strong

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Neutral

Dividends

Very Strong

Quality

Capital Efficiency

Strong

Balance Sheet

Very Strong

About HLS

Website

Healius Limited

Telephone

61.2.9432.9400

Address

Level 22 161 Castlereagh Street Liberty Place Sydney, New South Wales (NSW) 2000

Description

Healius Ltd. engages in the provision of healthcare technology solutions. It operates through the following segments: Pathology, Imaging, and Other. The Pathology segment provides pathology services. The Imaging segment focuses on imaging services from stand-alone imaging sites, hospitals, and medical centers. The Other segment consists of corporate functions. The company was founded by Edmund Gregory Thomas Bateman in 1985 and is headquartered in St. Leonards, Australia.

HLS Price Chart

Key Stats

Market Cap

AU$1.07B

PE

54.40

EV/EBITDA

6.7

Dividends Overview

DIV Yield

.5%

Franking

100%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.08 - 2.82

Trade Value (12mth)

AU$908,686.00

1 week

1.03%

1 month

-0.68%

YTD

-11.45%

1 year

-45.42%

All time high

9.10

Key Fundamentals

EPS 3 yr Growth

437.500%

EBITDA Margin

21.80%

Operating Cashflow

$306m

Free Cash Flow Return

9.40%

ROIC

-11.70%

Interest Coverage

6.00

Quick Ratio

0.50

Other Data

Shares on Issue (Fully Dilluted)

594m

HALO Sector

Healthcare

Next Company Report Date

21-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

7.44

HLS Announcements

Latest Announcements

Date Announcements

16 July 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

15 July 24

Change in substantial holding

×

Change in substantial holding

25 June 24

Healius announces Trading Update for FY 2024

×

Healius announces Trading Update for FY 2024

24 June 24

Change in substantial holding

×

Change in substantial holding

14 June 24

Healius announces Group Executive of Pathology departure

×

Healius announces Group Executive of Pathology departure

06 June 24

Change in substantial holding

×

Change in substantial holding

06 June 24

Change in substantial holding from PPT

×

Change in substantial holding from PPT

27 May 24

Update on Strategic Review and Chair Appointment

×

Update on Strategic Review and Chair Appointment

23 May 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

17 May 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

17 May 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

17 May 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

17 May 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

14 May 24

Becoming a substantial holder

×

Becoming a substantial holder

14 May 24

Healius Refinances Debt Facilities to March 2027

×

Healius Refinances Debt Facilities to March 2027

08 May 24

Change in substantial holding from PPT

×

Change in substantial holding from PPT

06 May 24

Becoming a substantial holder

×

Becoming a substantial holder

26 April 24

Becoming a substantial holder

×

Becoming a substantial holder

26 March 24

Becoming a substantial holder

×

Becoming a substantial holder

22 March 24

Change in substantial holding

×

Change in substantial holding

20 March 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

18 March 24

Application for quotation of securities - HLS

×

Application for quotation of securities - HLS

18 March 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

18 March 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

08 March 24

Change in substantial holding from PPT

×

Change in substantial holding from PPT

HLS Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.08 0.50 -0.61 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.08 0.49 -0.61 Lock Lock Lock
     Growth % Lock Lock Lock Lock 174.2 494.5 -221.8 Lock Lock Lock
     PE X Lock Lock Lock Lock 19.9 7.1 54.4 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 6.4 3.5 6.7 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.66 1.08 0.51 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.62 0.67 0.34 Lock Lock Lock
     Growth % Lock Lock Lock Lock -0.4 65.2 -52.7 Lock Lock Lock
     Yield % Lock Lock Lock Lock 13.4 18.2 11.6 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.13 0.16 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 409.6 20.8 -100.0 Lock Lock Lock
     Yield % Lock Lock Lock Lock 2.6 4.7 0.5 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 158 32 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 3.10 3.38 2.45 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock -0.44 -0.87 -0.75 Lock Lock Lock
     Growth % Lock Lock Lock Lock -44.4 -100.4 13.7 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 627 592 616 Lock Lock Lock
Basic m Lock Lock Lock Lock 619 584 616 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 1,901 2,336 1,707 Lock Lock Lock
     Growth % Lock Lock Lock Lock 22.1 22.9 -26.9 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 285 323 247 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 526 790 342 Lock Lock Lock
     Growth % Lock Lock Lock Lock 53.2 50.0 -56.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 27.7 33.8 20.0 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 72 66 80 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 503 746 372 Lock Lock Lock
     Growth % Lock Lock Lock Lock 67.1 48.4 -50.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock 26.4 31.9 21.8 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 247 278 277 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 255 467 95 Lock Lock Lock
     Growth % Lock Lock Lock Lock 196.6 83.0 -79.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 13.4 20.0 5.6 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 168 417 -397 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 102 123 -17 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 52 291 -375 Lock Lock Lock
     Growth % Lock Lock Lock Lock 173.8 460.4 -228.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 2.7 12.5 -21.9 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 493 574 306 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 61 94 76 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 387 -402 67 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -952 -164 -340 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 445 492 244 Lock Lock Lock
     Growth % Lock Lock Lock Lock 34.5 10.7 -50.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.2 0.2 0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 126 194 178 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 70 81 115 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 3,782 4,137 3,653 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1,211 1,555 1,503 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 1,366 1,698 1,651 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 1,925 2,215 2,147 Lock Lock Lock
Equity $m Lock Lock Lock Lock 1,857 1,922 1,506 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 3,069 3,477 3,009 Lock Lock Lock
     Growth % Lock Lock Lock Lock -12.5 13.3 -13.5 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 1.4 7.0 -10.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 2.8 15.2 -24.9 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 7.3 13.4 2.7 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 2.0 9.0 -11.7 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 15.0 17.5 9.4 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock 9.1 14.8 6.0 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 2.7 2.3 4.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 73.5 88.3 109.6 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 0.5 0.6 0.5 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 0.4 0.5 0.5 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 21.2 21.9 33.5 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 72.0 89.5 48.7 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 9.2 11.6 8.7 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 43.8 36.3 33.3 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 10.8 7.3 12.8 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.5 0.6 0.5 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.5 0.6 0.5 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 8.8 17.8 -23.3 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 4.4 10.1 -10.9 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 60.5 29.5 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 1.4 7.0 -10.3 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 2.0 2.2 2.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 2.8 15.2 -24.9 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock -57.7 68.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -1.6 10.3 -24.9 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 8.3 10.0 11.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 39.5 31.5 41.8 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 47.8 41.6 52.8 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 54.0 43.9 52.4 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -6.1 -2.3 0.3 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

.5%

Franking Level

100%

DPSg

-100.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

7.44%

Value ($M)

79

Prior Change

N/A

7 Day Change

-0.20%

1 Month Change

-0.20%

3 Month Change

1.70%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

HLS Shortsell

Frequently Asked Questions

The current share price of Healius Limited (HLS:ASX) is AU$1.46.
The 52-week high share price for Healius Limited (HLS:ASX) is AU$2.82.
The 52-week low share price for Healius Limited (HLS:ASX)? is AU$1.08.
The current TTM dividend payout for Healius Limited (HLS:ASX) is 0.50.
The last dividend payment of Healius Limited (HLS:ASX) is AU$0.06.
Healius Limited (HLS:ASX) has a franking level of 100.0%.
Healius Limited (HLS:ASX) is classified in the Healthcare.
The current P/E ratio for Healius Limited (HLS:ASX) is 54.40.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.